Foghorn Therapeutics

IPO

Unraveling Disease

Public · Watertown, United States · Founded 2016 · $336.4M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$336.4M
Last Round
$136.0M Series AJan 2026
Rounds
4
Type
Public

About

Foghorn Therapeutics is a clinical-stage biotechnology company pioneering a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Using its Gene Traffic Control® platform, the company identifies and validates targets to develop precision therapies for cancer and other serious diseases. Its lead programs include selective inhibitors and degraders targeting SMARCA2 and CBP/EP300. Headquartered in Watertown, Massachusetts.

Summary

Foghorn Therapeutics is a Biotech company based in Watertown, United States, founded in 2016. It has raised $336.4M in total across 4 rounds, most recently a $136.0M Series A round in Jan 2026.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundCorporate RoundJan 2026
$50.0M

Sign up to see all 5 rounds

Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Foghorn Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/foghorn-therapeutics"><img src="https://indexed.vc/api/badge/company/foghorn-therapeutics" alt="Foghorn Therapeutics on Indexed.vc" width="260" height="76" /></a>